EU says to purchase up to  mln doses of BioNTechPfizer vaccine
2020-11-11 09:24
FILE PHOTO Syringes are seen in front of displayed Biontech and Pfizer logos in this illustration taken November , .PhotoAgencies    BRUSSELS  The European Union EU will authorize a contract for the purchase of up to  million doses of the COVID vaccine jointly developed by German company BioNTech and its American partner Pfizer, European Commission President Ursula von der Leyen said on Tuesday. This is the most promising vaccine so far, she said on Twitter. The contract, due to be reached on Wednesday, will be the fourth one the EU secures with a pharmaceutical company to buy vaccines for COVID. The BioNTechPfizer vaccine candidate has proved to be more than  percent effective in preventing COVID infection in participants with no proven previous SARSCoV infection, the two companies announced on Monday. As the world is struggling to contain the COVID pandemic, countries including Germany, China, Russia, the United Kingdom and the United States are racing to find a vaccine. According to the website of the World Health Organization, as of Nov. , there were  COVID candidate vaccines being developed worldwide, and  of them were in clinical trials.